ECSP034636A - Uso de 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria - Google Patents

Uso de 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria

Info

Publication number
ECSP034636A
ECSP034636A EC2003004636A ECSP034636A ECSP034636A EC SP034636 A ECSP034636 A EC SP034636A EC 2003004636 A EC2003004636 A EC 2003004636A EC SP034636 A ECSP034636 A EC SP034636A EC SP034636 A ECSP034636 A EC SP034636A
Authority
EC
Ecuador
Prior art keywords
urinary incontinence
phenyl
cyclhexaco
dimethylaminome
replaced
Prior art date
Application number
EC2003004636A
Other languages
English (en)
Inventor
Elmar Josef Friderichs
Thomas Christoph
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of ECSP034636A publication Critical patent/ECSP034636A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere al uso de 6-dimetilaminometil-1-fenil-ciclohexano sustituido como bases libres y/o en forma de sales fisiológicamente admisibles para preparar un medicamento para el tratamiento de impulso aumentado de orinar, es decir, incontinencia urinaria, así como los medicamentos respectivos para el manejo del impulso aumentado de orinar o incontinencia urinaria.
EC2003004636A 2000-11-30 2003-05-30 Uso de 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria ECSP034636A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10059411A DE10059411A1 (de) 2000-11-30 2000-11-30 Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz

Publications (1)

Publication Number Publication Date
ECSP034636A true ECSP034636A (es) 2003-07-25

Family

ID=7665209

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004636A ECSP034636A (es) 2000-11-30 2003-05-30 Uso de 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria

Country Status (27)

Country Link
US (1) US6908944B2 (es)
EP (1) EP1337246B1 (es)
JP (1) JP4287143B2 (es)
KR (1) KR100827217B1 (es)
CN (1) CN1321634C (es)
AT (1) ATE320797T1 (es)
AU (2) AU3320902A (es)
BR (1) BR0115880A (es)
CA (1) CA2430279C (es)
CY (1) CY1105317T1 (es)
CZ (1) CZ304062B6 (es)
DE (2) DE10059411A1 (es)
DK (1) DK1337246T3 (es)
EC (1) ECSP034636A (es)
ES (1) ES2260306T3 (es)
HU (1) HU228775B1 (es)
IL (2) IL156169A0 (es)
MX (1) MXPA03004711A (es)
NO (1) NO333953B1 (es)
NZ (1) NZ526605A (es)
PL (1) PL204346B1 (es)
PT (1) PT1337246E (es)
RU (1) RU2280444C2 (es)
SI (1) SI1337246T1 (es)
SK (1) SK287701B6 (es)
WO (1) WO2002043712A2 (es)
ZA (1) ZA200305001B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2815691B1 (fr) * 2000-10-20 2003-08-15 Valois Sa Bille de clapet
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
DE50312678D1 (de) * 2002-11-22 2010-06-10 Gruenenthal Gmbh Verwendung von (1R, 2R)-3-(3-Dimenthylamino-1-ethyl-2-methyl-propyl)-phenol zur Behandlung von Entzündungsschmerz
DE10356362A1 (de) 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
US20090104266A1 (en) * 2005-09-15 2009-04-23 Tobias Jung 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR955065A (es) * 1947-01-13 1950-01-07
US4371720A (en) * 1980-09-19 1983-02-01 Pfizer Inc. 2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
WO1995004051A1 (en) * 1993-07-30 1995-02-09 The Wellcome Foundation Limited Piperazine compounds used in therapy
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
AU6747698A (en) * 1997-04-11 1998-11-11 Nippon Shinyaku Co. Ltd. Remedies for frequent urination and urinary incontinence
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten

Also Published As

Publication number Publication date
SI1337246T1 (sl) 2006-08-31
SK6642003A3 (en) 2003-10-07
CN1321634C (zh) 2007-06-20
DE10059411A1 (de) 2002-06-13
CZ304062B6 (cs) 2013-09-11
WO2002043712A3 (de) 2002-08-01
DK1337246T3 (da) 2006-07-03
MXPA03004711A (es) 2003-08-19
PT1337246E (pt) 2006-07-31
HK1058621A1 (en) 2004-05-28
AU3320902A (en) 2002-06-11
PL204346B1 (pl) 2010-01-29
NZ526605A (en) 2005-06-24
CN1487830A (zh) 2004-04-07
WO2002043712A2 (de) 2002-06-06
IL156169A (en) 2006-12-31
NO20032407L (no) 2003-05-27
IL156169A0 (en) 2003-12-23
US6908944B2 (en) 2005-06-21
BR0115880A (pt) 2004-01-06
CA2430279A1 (en) 2002-06-06
CY1105317T1 (el) 2010-03-03
HUP0303046A2 (hu) 2003-12-29
US20040043968A1 (en) 2004-03-04
JP4287143B2 (ja) 2009-07-01
ZA200305001B (en) 2005-01-26
EP1337246A2 (de) 2003-08-27
EP1337246B1 (de) 2006-03-22
AU2002233209B2 (en) 2006-05-11
CZ20031507A3 (cs) 2003-10-15
ES2260306T3 (es) 2006-11-01
HU228775B1 (hu) 2013-05-28
KR20030055330A (ko) 2003-07-02
DE50109320D1 (de) 2006-05-11
NO333953B1 (no) 2013-10-28
CA2430279C (en) 2011-01-04
HUP0303046A3 (en) 2007-03-28
NO20032407D0 (no) 2003-05-27
JP2004514691A (ja) 2004-05-20
ATE320797T1 (de) 2006-04-15
PL362991A1 (en) 2004-11-15
SK287701B6 (sk) 2011-06-06
RU2280444C2 (ru) 2006-07-27
AU2002233209B9 (en) 2006-06-22
KR100827217B1 (ko) 2008-05-07

Similar Documents

Publication Publication Date Title
AR037109A1 (es) Uso de flibanserina
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
CY1120879T1 (el) Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος
CR8207A (es) Un conjugado citotoxico ca6 antigeno- especifico y metodos para utilizar el mismo
CR9181A (es) Antiangiogenesis terapia de autoinmunidad de enfermedad en pacientes a quienes a fallado la terapia previa
AR045179A1 (es) Uso de una combinacion de un inhibidor de la quinasa del receptor del factor de crecimiento epidermico y de agentes citotoxicos para el tratamiento e inhibicion del cancer
PA8637201A1 (es) Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa
AR059390A1 (es) Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
ES2191192T3 (es) Tienopirimidinas.
CY1112478T1 (el) Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
CR10327A (es) "PIRIDIN(3-4-b) PIRAZINONAS"
CY1110721T1 (el) Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις
UY28923A1 (es) Compuestos terapéuticos: piridina como estructura base
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ES2250416T3 (es) Estimulante de secreciohn de hormona de crecimiento.
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
SV2006002245A (es) 2-anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y su uso como medicamentos ref. p-sv-78.797/msu
ECSP077323A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
GT200500316A (es) Nuevas piridinureas de antranilamida como inhibidores de la quinasa receptora del factor de crecimiento vascular endotelial (vegf)
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR041942A1 (es) Derivados de 10-oxa -1-aza-dibenzo [a,d] ciclohepteno-7-carboxilico como antagonistas ccr1 para el tratamiento de la enfermedad desmielinizante inflamatoria